BioTech Drug Development Industry 
Healthcare IT Today
JANUARY 23, 2024
Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,
Society for Participatory Medicine
FEBRUARY 1, 2023
By the power vested in clinical research, the FDA now pronounces us patient and industry. The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. I’m here to deliver some great news: we tied the knot!
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare IT Today
APRIL 25, 2024
Mati Gil, CEO at AION Labs , stands at the forefront of this revolution, pioneering the use of AI to tackle the challenges inherent in the pharma industry. In a recent video interview below, he shared insights into how AI is transforming drug discovery, emphasizing the need for innovation in an industry marked by complexity and high stakes.
Digital Health Global
NOVEMBER 30, 2023
Furthermore, by fostering connectivity and automating tasks, DHTs reduce administrative burdens, accelerate recruitment, and improve overall trial transparency, ultimately contributing to faster and more reliable drug development. It has been used in various studies in Europe with great results.
Society for Participatory Medicine
JANUARY 27, 2022
The same definition of patient engagement applies to industry, except that the interventions lead to more human centered design and value-based care. Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users.
Digital Health Global
AUGUST 30, 2023
QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. QuantHealth proudly supports several large pharma companies, numerous biotechs, as well as CROs, and other industry partners.
Healthcare IT Today
JANUARY 8, 2024
The excitement around new tools took hold of all industries in 2023, and the potential is expansive. The unification of technology, services and pharmacovigilance expertise in the coming year will further enunciate the industry’s focus on patient safety. Dave Latshaw, CEO at BioPhy 1. Dave Latshaw, CEO at BioPhy 1.
Expert insights. Personalized for you.
122 
Let's personalize your content